by aparada | Apr 12, 2021 | News FJB, News IONTAS |
FairJourney Biologics enters next-generation antibody discovery collaboration with argenx Collaboration to leverage IONTAS proprietary mammalian display technology Differentiated antibody candidates that emerge from collaboration may advance into argenx immunology...
by aparada | Mar 8, 2021 | News FJB, News IONTAS, Sem categoria |
Diverse panel of novel target binders from IONTAS / FJB will be used to uncover functional antibodies to advance Quell’s engineered Treg cell therapy pipeline Cambridge, UK, Porto, Portugal, and London, UK – 08 March 2021: IONTAS Limited (IONTAS) and FairJourney...
by aparada | Feb 8, 2021 | News FJB, News IONTAS |
FairJourney Biologics Group introduces Flow Eighteen38 for protein production and antibody characterization services Flow Eighteen38 will provide purified proteins and data to accelerate the success of antibody projects Porto, Portugal, 8th February 2021: FairJourney...
by aparada | Feb 8, 2021 | News FJB, News IONTAS |
António Parada, CEO of FairJourney Biologics, was recently featured on TV to review last year’s challenges and successes and the companies plans for continued growth and innovation into 2021.
by aparada | Jan 19, 2021 | News FJB, News IONTAS |
To celebrate 30 years of antibody phage display and the wide up take of the technology, IONTAS have created a video on how this technique works and why it remains a powerful tool that continues to drive antibody discovery forward.
by aparada | Nov 23, 2020 | News FJB, News IONTAS, Press Release |
Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to advance autoimmune and inflammatory disease research Porto, Portugal, Cambridge and London, UK, 23rd November 2020: FairJourney Biologics S.A...
